Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Clinical & Developmental Immunology|January 22, 2011
Immunotherapy for renal cell carcinomaMomoe Itsumi, Katsunori TatsugamiEuropean Journal of Immunology|June 23, 2009
IL-15 is critical for the maintenance and innate functions of self-specific CD8(+) T cellsMomoe Itsumi, Yasunobu Yoshikai, Hisakata YamadaJournal of Cellular Biochemistry|August 4, 2017
A20 restores phorbol ester-induced differentiation of THP-1 cells in the absence of nuclear factor-κB activationMiho Osako, Momoe Itsumi, Haruka Yamaguchi, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Identification of CD25+ gamma delta T cells as fetal thymus-derived naturally occurring IL-17 producersKensuke Shibata, Hisakata Yamada, Risa Nakamura, et al.Microbiology and Immunology|April 10, 2010
Dual specificity phosphatase16 is a negative regulator of c-Jun NH2-terminal kinase activity in T cellsShino Kumabe, Momoe Itsumi, Hisakata Yamada, et al.Lower Urinary Tract Symptoms|January 12, 2019
Mirabegron induces relaxant effects via cAMP signaling-dependent and -independent pathways in detrusor smooth muscleTomoko Maki, Shunichi Kajioka, Momoe Itsumi, et al.Biochemical and Biophysical Research Communications|November 8, 2017
Overexpression of exchange protein directly activated by cAMP-1 (EPAC1) attenuates bladder cancer cell migrationHirona Ichikawa, Momoe Itsumi, Shunichi Kajioka, et al.The Prostate|April 25, 2012
Downregulation of phosphodiesterase 4B (PDE4B) activates protein kinase A and contributes to the progression of prostate cancerEiji Kashiwagi, Masaki Shiota, Akira Yokomizo, et al.Endocrine-Related Cancer|March 16, 2013
Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cellsEiji Kashiwagi, Masaki Shiota, Akira Yokomizo, et al.International Journal of Oncology|February 21, 2012
Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylationArio Takeuchi, Masatoshi Eto, Masaki Shiota, et al.Pageof 5